The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

Sweeping layoffs, funding freezes and executive orders have provoked outcry among federal researchers and their university partners, who fear that science itself is under siege.

The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

How do you reschedule a whole round of review?” A NIH spokesperson did not answer questions from The Hill about the scope and reason behind the cancelations. An agency spokesperson instead sent ...

An email from an NIH official to a group that reviews federal grant applications for scientific research stated the following: "At the present time, all federal advisory committee meetings are ...

With recently reported restrictions that the Trump administration has placed on the NIH, that source’s future is unclear ... Officials there are waiting and watching, a spokesman said. “The short ...

The NIH will drastically cut funding for the indirect ... Across the country, college officials were panicking and scrambling to find answers. The American Council on Education held an emergency ...

The big losers would include prestigious institutions in conservative states. The NIH, the nation’s top funder of biomedical research, announced on Friday that it would substantially limit ...

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

Under GOP Sen. Doug Mastriano's proposal, the Pennsylvania DOGE could instantly stop spending what it deems unnecessary.

Research leaders contend that the NIH decision will damage America’s ability to compete with China and other nations on the frontier of biomedicine. Although it is framed as a simple cost ...